Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City
Introduction To assess the cost-effectiveness of a multidisciplinary and comprehensive innovative diabetes care program (CAIPaDi) versus usual treatment in public health institutions.Research design and methods Using a cost-effectiveness analysis, we compared the CAIPaDi program versus usual treatme...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-03-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/9/1/e002097.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850123609278775296 |
|---|---|
| author | Enrique O Graue-Hernandez Sergio Hernandez-Jimenez David Kershenobich-Stalnikowitz Ana Cristina García-Ulloa Carlos Alberto Aguilar-Salinas Denise Arcila-Martínez Rodrigo Arizmendi-Rodríguez Humberto Del Valle-Ramírez Fernanda Garnica-Carrillo Eduardo González-Flores Mariana Granados-Arcos Héctor Infanzón-Talango Claudia Lechuga-Fonseca Liliana Pérez-Peralta David Rivera de la Parra Sofía Ríos-Villavicencio Francis Rojas-Torres Sandra Sainos-Muñoz Alejandra Sierra-Esquivel Luz Elena Urbina-Arronte María Luisa Velasco-Pérez Héctor Velázquez-Jurado Andrea Villegas-Narváez Verónica Zurita-Cortés María Teresa Alcántara-Garcés Michelle Díaz-Pineda Arturo Flores García María Victoria Landa-Anell Marco Antonio Melgarejo-Hernández Pablo Anaya Ricardo Gasca-Pineda Luis Arturo Sánchez-Trujillo Héctor Peña Baca Eduardo González-Pier Franciso Javier Gómez-Pérez Angélica Palacios-Vargas Diana Hernández-Juárez Arely Hernández-Jasso |
| author_facet | Enrique O Graue-Hernandez Sergio Hernandez-Jimenez David Kershenobich-Stalnikowitz Ana Cristina García-Ulloa Carlos Alberto Aguilar-Salinas Denise Arcila-Martínez Rodrigo Arizmendi-Rodríguez Humberto Del Valle-Ramírez Fernanda Garnica-Carrillo Eduardo González-Flores Mariana Granados-Arcos Héctor Infanzón-Talango Claudia Lechuga-Fonseca Liliana Pérez-Peralta David Rivera de la Parra Sofía Ríos-Villavicencio Francis Rojas-Torres Sandra Sainos-Muñoz Alejandra Sierra-Esquivel Luz Elena Urbina-Arronte María Luisa Velasco-Pérez Héctor Velázquez-Jurado Andrea Villegas-Narváez Verónica Zurita-Cortés María Teresa Alcántara-Garcés Michelle Díaz-Pineda Arturo Flores García María Victoria Landa-Anell Marco Antonio Melgarejo-Hernández Pablo Anaya Ricardo Gasca-Pineda Luis Arturo Sánchez-Trujillo Héctor Peña Baca Eduardo González-Pier Franciso Javier Gómez-Pérez Angélica Palacios-Vargas Diana Hernández-Juárez Arely Hernández-Jasso |
| author_sort | Enrique O Graue-Hernandez |
| collection | DOAJ |
| description | Introduction To assess the cost-effectiveness of a multidisciplinary and comprehensive innovative diabetes care program (CAIPaDi) versus usual treatment in public health institutions.Research design and methods Using a cost-effectiveness analysis, we compared the CAIPaDi program versus usual treatment given in Mexican public health institutions. The analysis was based on the IQVIA Core Diabetes Model, a validated simulation model used to estimate long-term clinical outcomes. Data were prospectively obtained from the CAIPaDi program and from public databases and published papers. Health outcomes were expressed in terms of life-years gained and quality-adjusted life years (QALYs). Health and economic outcomes were estimated from a public perspective and discounted at 5% per year over a 20-year horizon. Costs are reported in US dollars (US$) of 2019. A probabilistic sensitivity analysis was performed using life-years gained and QALYs.Results The CAIPaDi costs on average US$559 (95% CI: −$879 to −$239) less than the usual treatment (95% CI: −$879 to −$239) and produced a difference in mean life-years gained (0.48, 95% CI: 0.45 to 0.52) and mean QALYs (1.43, 95% CI: 1.40 to 1.46). The cost-effectiveness ratio resulted in a saving per life-year gained of −US$1155 (95% CI: −$1962 to −$460). Mean differences in QALYs resulted in a saving per QALY of −US$735 (95% CI: −$1193 to −$305). Probabilistic sensitivity analysis proved the results are robust on both life-years gained and QALYs.Conclusions CAIPaDi has a better cost-effectiveness ratio than the usual therapy in Mexican public health institutions. |
| format | Article |
| id | doaj-art-52b8ea1daec1424f94913b77c1e1dbdf |
| institution | OA Journals |
| issn | 2052-4897 |
| language | English |
| publishDate | 2021-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open Diabetes Research & Care |
| spelling | doaj-art-52b8ea1daec1424f94913b77c1e1dbdf2025-08-20T02:34:33ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972021-03-019110.1136/bmjdrc-2020-002097Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico CityEnrique O Graue-Hernandez0Sergio Hernandez-Jimenez1David Kershenobich-Stalnikowitz2Ana Cristina García-Ulloa3Carlos Alberto Aguilar-Salinas4Denise Arcila-MartínezRodrigo Arizmendi-RodríguezHumberto Del Valle-RamírezFernanda Garnica-Carrillo5Eduardo González-FloresMariana Granados-ArcosHéctor Infanzón-TalangoClaudia Lechuga-FonsecaLiliana Pérez-PeraltaDavid Rivera de la ParraSofía Ríos-VillavicencioFrancis Rojas-TorresSandra Sainos-MuñozAlejandra Sierra-EsquivelLuz Elena Urbina-ArronteMaría Luisa Velasco-PérezHéctor Velázquez-JuradoAndrea Villegas-NarváezVerónica Zurita-CortésMaría Teresa Alcántara-GarcésMichelle Díaz-Pineda6Arturo Flores GarcíaMaría Victoria Landa-AnellMarco Antonio Melgarejo-HernándezPablo Anaya7Ricardo Gasca-Pineda8Luis Arturo Sánchez-Trujillo9Héctor Peña Baca10Eduardo González-Pier11Franciso Javier Gómez-Pérez12Angélica Palacios-VargasDiana Hernández-JuárezArely Hernández-JassoDepartment of Cornea and Refractive Surgery, Instituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City, MexicoCentro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Departamento Endocrinologia y Metabolismo, Tlalpan, MexicoNational Institute of Medical Sciences and Nutrition Salvador Zubiran, Tlalpan, MexicoCAIPaDi, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Tlalpan, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoCentro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Departamento Endocrinologia y Metabolismo, Tlalpan, MexicoCentro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Departamento Endocrinologia y Metabolismo, Tlalpan, MexicoIQVIA, Fairfax, Virginia, USAReal-World Insights, IQVIA, Mexico City, MexicoReal-World Insights, IQVIA, Mexico City, MexicoBlutitude Health Care Intelligence, Mexico City, MexicoBlutitude Health Care Intelligence, Mexico City, MexicoEndocrinology and Metabolism, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Tlalpan, MexicoIntroduction To assess the cost-effectiveness of a multidisciplinary and comprehensive innovative diabetes care program (CAIPaDi) versus usual treatment in public health institutions.Research design and methods Using a cost-effectiveness analysis, we compared the CAIPaDi program versus usual treatment given in Mexican public health institutions. The analysis was based on the IQVIA Core Diabetes Model, a validated simulation model used to estimate long-term clinical outcomes. Data were prospectively obtained from the CAIPaDi program and from public databases and published papers. Health outcomes were expressed in terms of life-years gained and quality-adjusted life years (QALYs). Health and economic outcomes were estimated from a public perspective and discounted at 5% per year over a 20-year horizon. Costs are reported in US dollars (US$) of 2019. A probabilistic sensitivity analysis was performed using life-years gained and QALYs.Results The CAIPaDi costs on average US$559 (95% CI: −$879 to −$239) less than the usual treatment (95% CI: −$879 to −$239) and produced a difference in mean life-years gained (0.48, 95% CI: 0.45 to 0.52) and mean QALYs (1.43, 95% CI: 1.40 to 1.46). The cost-effectiveness ratio resulted in a saving per life-year gained of −US$1155 (95% CI: −$1962 to −$460). Mean differences in QALYs resulted in a saving per QALY of −US$735 (95% CI: −$1193 to −$305). Probabilistic sensitivity analysis proved the results are robust on both life-years gained and QALYs.Conclusions CAIPaDi has a better cost-effectiveness ratio than the usual therapy in Mexican public health institutions.https://drc.bmj.com/content/9/1/e002097.full |
| spellingShingle | Enrique O Graue-Hernandez Sergio Hernandez-Jimenez David Kershenobich-Stalnikowitz Ana Cristina García-Ulloa Carlos Alberto Aguilar-Salinas Denise Arcila-Martínez Rodrigo Arizmendi-Rodríguez Humberto Del Valle-Ramírez Fernanda Garnica-Carrillo Eduardo González-Flores Mariana Granados-Arcos Héctor Infanzón-Talango Claudia Lechuga-Fonseca Liliana Pérez-Peralta David Rivera de la Parra Sofía Ríos-Villavicencio Francis Rojas-Torres Sandra Sainos-Muñoz Alejandra Sierra-Esquivel Luz Elena Urbina-Arronte María Luisa Velasco-Pérez Héctor Velázquez-Jurado Andrea Villegas-Narváez Verónica Zurita-Cortés María Teresa Alcántara-Garcés Michelle Díaz-Pineda Arturo Flores García María Victoria Landa-Anell Marco Antonio Melgarejo-Hernández Pablo Anaya Ricardo Gasca-Pineda Luis Arturo Sánchez-Trujillo Héctor Peña Baca Eduardo González-Pier Franciso Javier Gómez-Pérez Angélica Palacios-Vargas Diana Hernández-Juárez Arely Hernández-Jasso Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City BMJ Open Diabetes Research & Care |
| title | Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City |
| title_full | Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City |
| title_fullStr | Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City |
| title_full_unstemmed | Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City |
| title_short | Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City |
| title_sort | cost effectiveness of a self management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in mexico city |
| url | https://drc.bmj.com/content/9/1/e002097.full |
| work_keys_str_mv | AT enriqueograuehernandez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT sergiohernandezjimenez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT davidkershenobichstalnikowitz costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT anacristinagarciaulloa costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT carlosalbertoaguilarsalinas costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT denisearcilamartinez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT rodrigoarizmendirodriguez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT humbertodelvalleramirez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT fernandagarnicacarrillo costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT eduardogonzalezflores costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT marianagranadosarcos costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT hectorinfanzontalango costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT claudialechugafonseca costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT lilianaperezperalta costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT davidriveradelaparra costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT sofiariosvillavicencio costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT francisrojastorres costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT sandrasainosmunoz costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT alejandrasierraesquivel costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT luzelenaurbinaarronte costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT marialuisavelascoperez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT hectorvelazquezjurado costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT andreavillegasnarvaez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT veronicazuritacortes costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT mariateresaalcantaragarces costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT michellediazpineda costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT arturofloresgarcia costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT mariavictorialandaanell costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT marcoantoniomelgarejohernandez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT pabloanaya costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT ricardogascapineda costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT luisarturosancheztrujillo costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT hectorpenabaca costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT eduardogonzalezpier costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT francisojaviergomezperez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT angelicapalaciosvargas costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT dianahernandezjuarez costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity AT arelyhernandezjasso costeffectivenessofaselfmanagementandcomprehensivetraininginterventioninpatientswithtype2diabetesupto5yearsofdiagnosisinaspecializedhospitalinmexicocity |